Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zanzarini IDS"'
Autor:
Zanzarini IDS; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana., Barbosa G; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana., Prado LO; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana., Zattoni IF; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana., Da Paz G; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana., Prado ALD; Graduate Program in Pharmaceutical Sciences, Federal University of Parana; Federal Institute of Parana., Volanski W; Graduate Program in Pharmaceutical Sciences, Federal University of Parana., Lavarda MD; Federal Institute of Parana., Rego FGM; Graduate Program in Pharmaceutical Sciences, Federal University of Parana., Picheth G; Graduate Program in Pharmaceutical Sciences, Federal University of Parana., Moure VR; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana., Valdameri G; Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana; gvaldameri@ufpr.br.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2023 Jan 13 (191). Date of Electronic Publication: 2023 Jan 13.
Autor:
Kita DH; Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, Brazil.; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., de Andrade GA; Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, Brazil., Missina JM; Department of Chemistry, Federal University of Paraná, Curitiba, Brazil., Postal K; Department of Chemistry, Federal University of Paraná, Curitiba, Brazil., Boell VK; Department of Chemistry, Federal University of Paraná, Curitiba, Brazil., Santana FS; Department of Chemistry, Federal University of Paraná, Curitiba, Brazil., Zattoni IF; Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, Brazil., Zanzarini IDS; Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, Brazil., Moure VR; Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, Brazil.; Department of Clinical Analysis, Federal University of Paraná, Curitiba, Brazil., Rego FGM; Department of Clinical Analysis, Federal University of Paraná, Curitiba, Brazil., Picheth G; Department of Clinical Analysis, Federal University of Paraná, Curitiba, Brazil., de Souza EM; Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Brazil., Mitchell DA; Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Brazil., Ambudkar SV; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nunes GG; Department of Chemistry, Federal University of Paraná, Curitiba, Brazil., Valdameri G; Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Paraná, Curitiba, Brazil.; Department of Clinical Analysis, Federal University of Paraná, Curitiba, Brazil.
Publikováno v:
FEBS letters [FEBS Lett] 2022 Feb; Vol. 596 (3), pp. 381-399. Date of Electronic Publication: 2021 Dec 30.